Skip to content

Study · Animal study (in vivo) · rat · 2009

1 result

AMP-activated protein kinase response to contractions and treatment with the AMPK activator AICAR in young adult and old skeletal muscle.

Thomson DM, Brown JD, Fillmore N, Ellsworth SK, Jacobs DL, Winder WW, Fick CA, Gordon SE

The Journal of physiology9 Mar 2009Cited by 32 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Mechanism

    In rats, AMPK alpha2 activity responded equally to AICAR in old and young adult muscles.

    In plain wordsIn rats, old and young adult muscles showed equal AMPK alpha2 activity responses to AICAR.

    Outcome
    No significant changeAMPK alpha2 activity response
    Study

    ratn: not reported in source

    Fischer(344) x Brown Norway skeletal muscle
    Comparator
    young adult rats
    Outcome group
    Receptor activity and mechanism · Musculoskeletal
    Studied dose
    1 mg (g body weight)(-1) · subcutaneous · 1 hAs given in this study (rat).

    Source sentences

    Summary
    In contrast, AMPK alpha2 activity was equally responsive to AICAR treatment in both age groups.
    2 context sentences
    Summary · context
    Here we tested the hypothesis that AMPK would also be hyperactivated in O vs YA fast-twitch extensor digitorum longus muscles from Fischer(344) x Brown Norway (FBN) rats (n = 8 per group) in response to high-frequency electrical stimulation of the sciatic nerve (HFES) or injection of AICAR, an activator of AMPK.
    Summary · context
    Muscles were harvested immediately after HFES (10 sets of six 3-s contractions, 10 s rest between contractions, 1 min rest between sets) or 1 h after AICAR injection (1 mg (g body weight)(-1) subcutaneously).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.